Bids Are Invited For Price Registration For Future And Possible Acquisition Of Medicines Intended To Meet The Demands Of The Health Secretariat With The Municipal Health Network, In Accordance With The Specifications And Quantitatives Established In The Notice And Its Annexes.

Acebrophylline 10Mg/Ml, Syrup With 120Ml + Graduated Dosage., Acebrophylline 5Mg/Ml, Retinol Acetate 10,000 Iu, Amino Acids 25 Mg, Methionine 5 Mg, Chloraphenicol 5 Mg, Packaging 3.5 Grams., Acetylcysteine ​​100 Mg/Ml, 03 Ml Ampoule. Use: Ev/Im/Inhalation/Endotrachiobronchial., Acetylcysteine ​​40 Mg/Ml, Pharmaceutical Form Syrup, Presentation Form Bottle Containing 120Ml With Dosing Cup, Oral Administration Route. Label Containing Date Of Manufacturing, Batch Number, Manufacturer Identification And Expiration Date. It Must Comply With Current Health Legislation., 20/12/2024, Aciclovir 200 Mg, Tablet, Primary And Secondary Packaging, According To The Publication Of The Registration In The Ministry Of Health., Aciclovir 250 Mg 250 Mg Solucao Injetavel - Forma Pharmaceutical Lyophilized Powder For Injected Solution, Vial Presentation Form Ampoule, Intravenous Administration Route, Acetyl Salicylic Acid 100Mg Tablet. Primary And Secondary Packaging, Ascorbic Acid 100 Mg/Ml, Injectable Solution, 5 Ml., Ascorbic Acid Concentration/Dosage 200 Mg/Ml, Pharmaceutical Form Injectable Solution, Ampoule Presentation Form, Parenteral Route Of Administration., Folic Acid 05 Mg Tablet . Primary And Secondary Packaging, Folinic Acid 15 Mg. Tablet Presentation. Oral Route Of Administration. Label Containing Date Of Manufacture, Tranexamic Acid 50 Mg/Ml. Injectable Solution. 05 Ml Ampoule, Valproic Acid 500 Mg Tablet, Sodium Valproate. Primary And Secondary Packaging, Essential Fatty Acids - Age Composition: Linoleic Acid, Oleic Acid, Caprylic Acid, Capric Acid, Lauric Acid, Palmitic Acid, Myristic Acid, Stearic Acid, Retinol Palmitate (Vitamin A), Tocopheryl Acetate (Vitamin E ) And Soy Lecithin. Packaging Containing 100 Ml., Tocopheryl Acetate (Vitamin E) And Soy Lecithin. Packaging Containing 200 Ml., Adenosine 3 Mg/Ml. Injectable Solution, 02 Ml Ampoule, Distilled Water - 10 Ml Sterile And Non-Pyrogenic. Injectable Solution 10 Ml Ampoule, Distilled Water - 1000 Ml. Sterile And Non-Pyrogenic Injectable Solution, Closed System Of 1000 Ml. (Bag), Sterile And Non-Pyrogenic Distilled Water Injectable Solution, 500 Ml Closed System. (Pouch), Albendazole - 400 Mg Tablet 400 Mg Tablet, Chewable. Primary And Secondary Packaging, According To The Publication Of The Registration With The Ministry Of Health., Albendazole 40 Mg-Ml. Oral Suspension 10 Ml, With Security Seal. Primary And Secondary Packaging, Human Albumin 20%, Ampoule With 10 G In 50 Ml, Intravenous Solution., Alteplase - 50 Mg Concentration/Dosage 50 Mg, Pharmaceutical Form Lyophilized Powder For Injectable Solution, Presentation Form Ampoule Vial + Diluent 50 Ml , Intravenous Administration Route, Ambroxol Hydrochloride 3 Mg/Ml, Pediatric, 120 Ml Syrup + Graduated Dosage., Ambroxol Hydrochloride 6 Mg/Ml, Adult, Amikacin Sulfate 250 Mg/Ml, Aminophylline 24 Mg/Ml, Im/Iv, 10 Ml., Amoxicillin + Clavulanate Of Potassium 1 G Concentration/Dosage 1 G + 200 Mg Respectively, Ampoule-Vial Presentation Form, Intravenous Administration Route., Amoxicillin + Potassium Clavulanate 500 + 100 Mg, Lyophilic Powder, Injectable For Intravenous Use., Amoxicillin + Potassium Clavulanate Tablet 500 + 125 Mg, Individual Packaging In Cartridge, In Packaging Primary And Secondary, Amoxicillin + Potassium Clavulanate Free Distribution, 50 Mg + 12.5 Mg/Ml, Powder For Oral Suspension, Bottle With 75 Ml + Dosing Syringe. Individual Packaging In Cartridge. Primary And Secondary Packaging, Amoxic